Connection
Ganesh Narayanasamy to Prostatic Neoplasms
This is a "connection" page, showing publications Ganesh Narayanasamy has written about Prostatic Neoplasms.
|
|
Connection Strength |
|
|
|
|
|
0.805 |
|
|
|
-
Narayanasamy G, Avila G, Mavroidis P, Papanikolaou N, Gutierrez A, Baacke D, Shi Z, Stathakis S. Comparison of composite prostate radiotherapy plan doses with dependent and independent boost phases. Australas Phys Eng Sci Med. 2016 Sep; 39(3):727-33.
Score: 0.419
-
Hammers J, Lindsay D, Narayanasamy G, Sud S, Tan X, Dooley J, Marks LB, Chen RC, Das SK, Mavroidis P. Evaluation of the clinical impact of the differences between planned and delivered dose in prostate cancer radiotherapy based on CT-on-rails IGRT and patient-reported outcome scores. J Appl Clin Med Phys. 2023 Jan; 24(1):e13780.
Score: 0.159
-
Hussain SS, Huang SB, Bedolla RG, Rivas P, Basler JW, Swanson GP, Hui-Ming Huang T, Narayanasamy G, Papanikolaou N, Miyamoto H, Yeh IT, Reddick RL, Pollock BH, Ghosh R, Kumar AP. Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation. Cancer Lett. 2018 10 01; 433:232-241.
Score: 0.119
-
Zhang X, Penagaricano J, Narayanasamy G, Corry P, Liu T, Sanjay M, Paudel N, Morrill S. Helical tomotherapy to LINAC plan conversion utilizing RayStation Fallback planning. J Appl Clin Med Phys. 2017 Jan; 18(1):178-185.
Score: 0.107
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|